Table 1

Vaccine coverage

StudyProvincial sitesInvited cohortConsented cohortInvited uptake rate
(%)
Vaccinated cohortConsented uptake rate
(%)
Single doseFirst two of intended three dosesVaccine completion rateSufficiently vaccinated rate
Target group=enrolled girls (n)Girls with consent and assent (n)Received at least one dose (n)Received only one vaccine dosage (n)Received two dosages, less than 6 months apart (n)Received intended number of doses
(n (%))
Received minimum two doses, 6 months apart
(n (%))
 VACCS1GP1654105964.0105399.49103870 (82.6)941 (89.4)
WC181198754.597799.01049912 (93.3)918 (94.0)
Totals 3465 2046 59.0 2030 99.2 19 152 1782 (87.8) 1859 (91.6)
 VACCS2GP96551953.751899.823NA495 (95.6)495 (95.6)
WC70750371.149899.019NA479 (96.2)479 (96.2)
Totals 1672 1022 61.1 1016 99.4 42 NA 974 (95.9) 974 (95.9)
Project totals 5137 3068 59.7 3046 99.3 213 2756 (90.5) 2833 (93.0)
  • GP, Gauteng Province; NA, not applicable; VACCS, Vaccine And Cervical Cancer Screen ; WC, Western Cape.